Key facts
- Novian Health’s last known valuation is $115.0M (Dec 2021).
- It has raised $32.5M across 2 recorded rounds; the latest was Early Stage VC ($5.3M) in Jan 2024.
- Notable investors include MedTech Innovator, Matter (Consulting Services (B2B)), Illinois Ventures, Audrey's Kitchen, Mantucket Capital — 6 tracked in total.
- Novian Health has filed 8 Form Ds with the SEC since 2021, most recently Sep 2025 ($4.7M sold to 25 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Novian Health
Funding rounds
2 roundsAbout Novian Health
Operator of a proprietary medical technology platform intended to help in the treatment of tumors for early-stage breast cancer using interstitial laser therapy. The company's technology is a minimally invasive procedure, an alternative to surgery for treating cancerous and non-cancerous breast tumors, enabling healthcare authorities to detect cancer at an early stage.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 1991
- Employees
- 10
- Website
- novianhealth.com/
- Ownership
- Privately Held (backing)
Novian Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Novian Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Novian Health in its N-PORT filings yet. We sweep new filings monthly.